These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 34062191)

  • 1. The heterogeneity of cancer endothelium: The relevance of angiogenesis and endothelial progenitor cells in cancer microenvironment.
    Armani G; Pozzi E; Pagani A; Porta C; Rizzo M; Cicognini D; Rovati B; Moccia F; Pedrazzoli P; Ferraris E
    Microvasc Res; 2021 Nov; 138():104189. PubMed ID: 34062191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classical and non-classical proangiogenic factors as a target of antiangiogenic therapy in tumor microenvironment.
    Marech I; Leporini C; Ammendola M; Porcelli M; Gadaleta CD; Russo E; De Sarro G; Ranieri G
    Cancer Lett; 2016 Sep; 380(1):216-26. PubMed ID: 26238184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
    Gacche RN; Meshram RJ
    Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting endothelial progenitor cells in cancer as a novel biomarker and anti-angiogenic therapy.
    Ammendola M; Leporini C; Luposella M; Sacco R; Sammarco G; Russo E; Patruno R; De Sarro G; Ranieri G
    Curr Stem Cell Res Ther; 2015; 10(2):181-7. PubMed ID: 25429701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology of tumor neovascularization.
    Furuya M; Nishiyama M; Kasuya Y; Kimura S; Ishikura H
    Vasc Health Risk Manag; 2005; 1(4):277-90. PubMed ID: 17315600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial Progenitors in the Tumor Microenvironment.
    Testa U; Pelosi E; Castelli G
    Adv Exp Med Biol; 2020; 1263():85-115. PubMed ID: 32588325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative Strategies to Inhibit Tumor Vascularization.
    Brossa A; Buono L; Fallo S; Fiorio Pla A; Munaron L; Bussolati B
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer stem cells and their vascular niche: Do they benefit from each other?
    Ping YF; Zhang X; Bian XW
    Cancer Lett; 2016 Oct; 380(2):561-567. PubMed ID: 25979233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Junctional Adhesion Molecule-C Mediates the Recruitment of Embryonic-Endothelial Progenitor Cells to the Perivascular Niche during Tumor Angiogenesis.
    Czabanka M; Petrilli LL; Elvers-Hornung S; Bieback K; Albert Imhof B; Vajkoczy P; Vinci M
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32054130
    [No Abstract]   [Full Text] [Related]  

  • 10. Angiogenesis after acute myocardial infarction.
    Wu X; Reboll MR; Korf-Klingebiel M; Wollert KC
    Cardiovasc Res; 2021 Apr; 117(5):1257-1273. PubMed ID: 33063086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editorial foreword special issue: "Angiogenesis-convergent or divergent, that is the question: Research toward targeted strategies in oncology".
    Cai J
    Cancer Lett; 2016 Oct; 380(2):523-524. PubMed ID: 27032878
    [No Abstract]   [Full Text] [Related]  

  • 12. Pathological angiogenesis and inflammation in tissues.
    Jeong JH; Ojha U; Lee YM
    Arch Pharm Res; 2021 Jan; 44(1):1-15. PubMed ID: 33230600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs and tumor vasculature normalization: impact on anti-tumor immune response.
    Matejuk A; Collet G; Nadim M; Grillon C; Kieda C
    Arch Immunol Ther Exp (Warsz); 2013 Aug; 61(4):285-99. PubMed ID: 23575964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of CYP4A by a novel flavonoid FLA-16 prolongs survival and normalizes tumor vasculature in glioma.
    Wang C; Li Y; Chen H; Zhang J; Zhang J; Qin T; Duan C; Chen X; Liu Y; Zhou X; Yang J
    Cancer Lett; 2017 Aug; 402():131-141. PubMed ID: 28602979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basic fibroblast growth factor induces VEGF expression in chondrosarcoma cells and subsequently promotes endothelial progenitor cell-primed angiogenesis.
    Tzeng HE; Chen PC; Lin KW; Lin CY; Tsai CH; Han SM; Teng CL; Hwang WL; Wang SW; Tang CH
    Clin Sci (Lond); 2015 Jul; 129(2):147-58. PubMed ID: 25735814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel drug targets for angiostatic cancer therapy; it takes two to tango.
    Thijssen VL; van Beijnum JR; Mayo KH; Griffioen AW
    Curr Pharm Des; 2007; 13(35):3576-83. PubMed ID: 18220794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dark side of tumor-associated endothelial cells.
    De Sanctis F; Ugel S; Facciponte J; Facciabene A
    Semin Immunol; 2018 Feb; 35():35-47. PubMed ID: 29490888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial progenitor cells support tumour growth and metastatisation: implications for the resistance to anti-angiogenic therapy.
    Moccia F; Zuccolo E; Poletto V; Cinelli M; Bonetti E; Guerra G; Rosti V
    Tumour Biol; 2015 Sep; 36(9):6603-14. PubMed ID: 26232913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rac Signaling Drives Clear Cell Renal Carcinoma Tumor Growth by Priming the Tumor Microenvironment for an Angiogenic Switch.
    Goka ET; Chaturvedi P; Lopez DTM; Lippman ME
    Mol Cancer Ther; 2020 Jul; 19(7):1462-1473. PubMed ID: 32371578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor angiogenesis: molecular pathways and therapeutic targets.
    Weis SM; Cheresh DA
    Nat Med; 2011 Nov; 17(11):1359-70. PubMed ID: 22064426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.